Peptide Synthesis Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029

  • Published: Aug 2025
  • Pages: 160

Peptide Synthesis Market Size 2025-2029

The global peptide synthesis market size is forecast to grow by USD 400-800 million at a CAGR of 11%-14% during the forecast period. Exact values for this market can be accessed upon purchasing the report. This market growth is being driven by the increasing demand for peptide-based therapeutics and custom peptide synthesis, expanding applications in diagnostics and imaging, advancements in therapies for rare diseases, and the rising demand for personalized and precision medicine. Peptide synthesis technologies, including innovations in solid-phase and liquid-phase synthesis methods, are contributing to this growth by offering high specificity, low toxicity, and efficient genetic activity. These advancements are further fueling the market’s expansion.

Peptide synthesis equipment and reagents play a crucial role in streamlining the production of high-quality peptides, supporting the development of peptide-based drug therapies. Additionally, the market is influenced by cost factors related to peptide synthesis, such as the need for cost-effective manufacturing methods and scalable solutions. The rising incidences of chronic diseases, including cancer, diabetes, and cardiovascular disorders, are driving the demand for peptide-based drug development, while pharmaceutical and biotechnology companies continue to leverage peptide synthesis for developing targeted, personalized treatments.

To access the full market forecast and comprehensive analysis, Buy Now

How is this Market Segmented?

info_market_segment

The peptide synthesis market is segmented according to product type, technology, and geography:

  • Product Type:
    • Equipment
    • Reagents & Consumables
    • Services
  • Technology:
    • Liquid Phase Peptide Synthesis (LPPS)
    • Solid Phase Peptide Synthesis (SPPS)
    • Hybrid Technology
  • Geography:
    • North America
      • Canada
      • US
    • APAC
      • China
      • India
      • Japan
      • South Korea
    • Europe
      • Germany
      • UK
      • France
    • South America
      • Brazil
    • Middle East and Africa

Regional Analysis

  • North America: Dominated the market in 2024, driven by advanced pharmaceutical sectors and strong healthcare infrastructure.
  • Europe: Shows significant growth, particularly in Germany and the UK, supported by research institutes and governmental support for peptide-based drug development.
  • APAC: Expected to grow at the fastest rate due to cost-effective peptide synthesis services and increasing investments in biotechnology.

Market Dynamics

Key Market Drivers:

  • Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.
  • Growing adoption of personalized medicine and precision therapeutics.
  • Advances in peptide synthesis technologies, enabling more efficient and scalable production.
  • The rise of peptide-based diagnostics, which enhances disease detection and management.

Market Trends:

  • The shift toward hybrid technologies that combine different synthesis methods for higher purity and yields.
  • The increasing role of peptides in precision medicine, where treatments are tailored to individual genetic profiles.
  • The surge in outsourcing peptide synthesis to contract manufacturers, driven by the high cost of in-house production.

Challenges:

  • High production costs associated with peptide synthesis, especially in the early stages of research and development.
  • Complexity in large-scale peptide production while maintaining high purity and specificity.
  • Regulatory hurdles and intellectual property concerns in the peptide synthesis industry.

Key Companies & Market Insights

Leading companies in the peptide synthesis market are focusing on strategic partnerships, technological advancements, and expansion of their product portfolios. Key players in this market include:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript
  • Bachem Holding AG
  • Biotage
  • Creative Diagnostics
  • PolyPeptide Group
  • Syngene International Limited
  • Puresynth Research Chemicals Pvt Ltd.
  • Lonza

Market Scope

Base Year

      2024

Forecast Period

      2025-2029

Market Size

      USD 400-800 Million

Market Growth

      11%-14%

Product Type

  • Equipment
  • Reagents & Consumables
  • Services

Technology

  • Liquid Phase Peptide Synthesis (LPPS)
  • Solid Phase Peptide Synthesis (SPPS)
  • Hybrid Technology

Regional Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript
  • Bachem Holding AG
  • Biotage
  • Creative Diagnostics
  • PolyPeptide Group
  • Syngene International Limited
  • Puresynth Research Chemicals Pvt Ltd.
  • Lonza
  • Others

For further information, Get Free Sample

How the Benefits of a Technavio Market Research Report Can Empower Your Business

Technavio’s reports provide a range of market insights, including:

  • A detailed analysis of the market, featuring market size, growth rate, segmentation, and regional performance
  • In-depth analysis of the drivers, challenges, and other dynamics that will impact the growth of the market
  • Predictions about upcoming trends and changes in consumer behavior
  • Detailed information on key market players, including market positioning, product offerings, and more
Image
Peptide Synthesis Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029
Interested in this report?
Get your sample now!